Jump Financial, LLC Nkarta, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.52 - $8.0 $303,766 - $537,640	-67,205 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$5.27 - $10.82 $354,170 - $727,158	67,205 New	67,205 $397,000
Q4 2022 Feb 13, 2023	BUY	$5.14 - $14.35 $194,065 - $541,798	37,756 New	37,756 $226,000
Q2 2022 Aug 09, 2022	BUY	$7.77 - $19.44 $269,619 - $674,568	34,700 Added 294.07%	46,500 $573,000
Q1 2022 May 12, 2022	SELL	$8.66 - $14.99 $271,058 - $469,187	-31,300 Reduced 72.62%	11,800 $134,000
Q4 2021 Feb 10, 2022	BUY	$12.79 - $26.88 $551,249 - $1.16 Million	43,100 New	43,100 $662,000
Q2 2021 Aug 13, 2021	SELL	$23.94 - $36.68 $294,509 - $451,237	-12,302 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$31.33 - $59.61 $385,421 - $733,322	12,302 New	12,302 $405,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $122M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.